Hepatitis C, Treatment and Drug Use in Australian Prison Settings
MetadataShow full item record
This thesis examined issues surrounding the hepatitis C virus (HCV), its treatment, and injecting drug use as the principal risk factor for infections in Australian prison environments. Quantitative and qualitative data was collected from both former and current prisoners to explore knowledge and attitudes towards treatment. Additional data concerning drug use was collected via existing national surveys. Epidemic modelling was used to determine the potential of increased prisoner engagement in treatment.
Showing items related by title, author, creator and subject.
A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisonersYap, L.; Carruthers, Susan; Thompson, S.; Cheng, W.; Jones, J.; Simpson, P.; Richards, A.; Thein, H.; Haber, P.; Lloyd, A.; Butler, Tony (2014)Background: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including ...
Stories and stats: a mixed methods study of staff and male prisoner patient experiences of prison based mental health servicesHancock, Kate (2009)One consequence of the deinstitutionalisation of psychiatric care and increase in community care is the rising number of mentally ill people in prison populations where there are insufficient mental health professionals ...
Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug useCurtis, M.; Dietze, P.; Aitken, C.; Kirwan, A.; Kinner, S.; Butler, Tony; Stoové, M. (2018)Background: Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention initiative. Elevated opioid overdose risk following prison release means release from custody provides an ideal opportunity ...